Penumbra Inc (PEN)
Data as of , from SEC Form 4 filings.
See up to 3 months of PEN. The 7-day demo opens the 1M and 3M ranges and puts PEN on your watchlist.
Start 7-day demoLatest PEN insider trades
Harpreet Grewal - DirectorOpen-market sale$33K- Maggie Yuen - OfficerOpen-market sale$832K
About Penumbra Inc (PEN)
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
- ALAMEDA, CA
- 4,700
- 2015
- XNYS
PEN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 3,060 | |
| Tax withholding / forfeiture | 1 | 1,230 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PEN insider transactions (Form 4)
1063 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Harpreet Grewal - Director | Open-market sale | Common Stock | 166 | $190.83 | $32K | |
 Johanna Roberts - Officer | Open-market sale | Common Stock | 21 | $187.32 | $4K | |
| Johanna Roberts - Officer | Open-market sale | Common Stock | 60 | $188.51 | $11K | |
| Johanna Roberts - Officer | Open-market sale | Common Stock | 73 | $189.67 | $14K | |
| Johanna Roberts - Officer | Open-market sale | Common Stock | 199 | $190.72 | $38K | |
| Johanna Roberts - Officer | Open-market sale | Common Stock | 184 | $191.65 | $35K | |
| Johanna Roberts - Officer | Open-market sale | Common Stock | 48 | $192.51 | $9K | |
| Johanna Roberts - Officer | Open-market sale | Common Stock | 12 | $193.73 | $2K | |
| Johanna Roberts - Officer | Open-market sale | Common Stock | 3 | $194.44 | $583 | |
| Don W. Kassing - Director | Open-market sale | Common Stock | 170 | $193.93 | $33K |
PEN insider trading FAQ
What is the latest insider trade for PEN?
Penumbra Inc (PEN) had 2 insider filings in the last 90 days, with the most recent on 2026-09-17. The full record for PEN runs to 63 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PEN stock?
No insider purchases of PEN were filed in the last 90 days.
How many insiders are selling PEN stock?
No insider sales of PEN were filed in the last 90 days. 121 sales are on record for this company.
Where can I see PEN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PEN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Shruthi Narayan view on EDGAR
- - Shruthi Narayan view on EDGAR
- - Adam Elsesser view on EDGAR
- - Harpreet Grewal view on EDGAR
- - Shruthi Narayan view on EDGAR
- - Johanna Roberts view on EDGAR
- - Maggie Yuen view on EDGAR
- - Lambert Shiu view on EDGAR
- - Maggie Yuen view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where PEN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PEN with a 7-day demo
- PEN on your watchlist
- Every PEN Form 4 filing on record
- Up to 3 months of PEN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
